Saturday, 31 October 2026European Markets

THE NAVIGATOR COMP, YARA INTERNATIONAL, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(VIANEWS) - THE NAVIGATOR COMP (NVG.LS) is among this list of stock assets with the highest dividend rate and return on equity on the Basic Materials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
THE NAVIGATOR COMP (NVG.LS) €3.71 17.54% 31.56%
YARA INTERNATIONAL (YAR.OL) kr359.20 15.4% 0.67%
OCI (OCI.AS) €27.54 6.22% 5.32%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. THE NAVIGATOR COMP (NVG.LS)

17.54% Forward Dividend Yield and 31.56% Return On Equity

The Navigator Company, S.A. manufactures and markets pulp and paper products worldwide. The company operates through Market Pulp, UWF Paper, Tissue Paper, and Biomass Renewable Energy segments. It produces bleached eucalyptus kraft pulp, uncoated writing and printing thin paper, and domestic consumption paper under the Navigator, Multioffice, Discovery, explorer, Inacopia, Target, Pioneer, SOPORSET, INASET, and target plus brands for professional and home use. The company also operates cogeneration units and two independent thermoelectric power plants. The company was formerly known as Portucel, S.A. and changed its name to The Navigator Company, S.A. in February 2016. The Navigator Company, S.A. was founded in 1953 and is headquartered in Setúbal, Portugal. The Navigator Company, S.A. operates as a subsidiary of Semapa - Sociedade de Investimento e Gestão, SGPS, S.A.

Earnings Per Share

As for profitability, THE NAVIGATOR COMP has a trailing twelve months EPS of €0.45.

PE Ratio

THE NAVIGATOR COMP has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing €8.24 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.56%.

Volume

Today's last reported volume for THE NAVIGATOR COMP is 175130 which is 64.65% below its average volume of 495517.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 17.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

THE NAVIGATOR COMP's EBITDA is 20.83.

More news about THE NAVIGATOR COMP.

2. YARA INTERNATIONAL (YAR.OL)

15.4% Forward Dividend Yield and 0.67% Return On Equity

Yara International ASA provides crop nutrition and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers ammonium- and urea-based fertilizers; compound fertilizers that contain plant nutrients, such as nitrogen, phosphorus, and potassium; coatings; biostimulants; organic-based fertilizers; green fertilizers are nitrate-based mineral fertilizers, as well as foliar and fertigation solutions; and nitrate, calcium nitrate, micronutrient, and fertigation fertilizers. It also offers digital solutions, such as variable rate application solutions; N-Sensor, a tractor-mounted hardware; N-Tester, a hand held nitrogen measurement tool; and Atfarm, a digital toolbox for farmer. The company sells its products under YaraBela, YaraMila, YaraLiva, YaraVita, YaraRega, YaraTera, YaraSuna, and YaraVera and brands. Yara International ASA was founded in 1905 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, YARA INTERNATIONAL has a trailing twelve months EPS of kr23.86.

PE Ratio

YARA INTERNATIONAL has a trailing twelve months price to earnings ratio of 15.05. Meaning, the purchaser of the share is investing kr15.05 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.67%.

More news about YARA INTERNATIONAL.

3. OCI (OCI.AS)

6.22% Forward Dividend Yield and 5.32% Return On Equity

OCI N.V. produces and distributes hydrogen-based and natural gas-based products to agricultural, transportation, and industrial customers. It operates through Methanol US, Methanol Europe, Nitrogen US, Nitrogen Europe, and Fertiglobe segments. The company offers anhydrous ammonia, granular urea, urea ammonium nitrate solution, calcium ammonium nitrate, ammonium sulphate, aqueous ammonia, nitric acid, urea solution, bio-methanol, methanol, melamine, and diesel exhaust fluid, as well as other nitrogen products. It also owns and operates an ammonia terminal at the port of Rotterdam. The company has operations in Europe, the Americas, the Middle East, Africa, Asia, and Oceania. OCI N.V. has a strategic partnership with Abu Dhabi National Oil Company. OCI N.V. was founded in 2013 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, OCI has a trailing twelve months EPS of €-1.09.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.32%.

More news about OCI.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com